Dr. Ramalingam, Res. ’97, named deputy director of Winship Cancer Institute at Emory

February 17, 2016

Suresh S. Ramalingam, M.D. Res. ’97, an internationally recognized lung cancer physician-investigator, has been named deputy director of Winship Cancer Institute of Emory University in Atlanta, Ga. He also will serve as assistant dean for Cancer Research for the Emory School of Medicine.

In his role as Winship’s deputy director, Dr. Ramalingam will lead the integration of the research, clinical and educational components within Winship.

“Dr. Ramalingam is an extraordinary leader and will advance Winship’s efforts to lessen the burden of cancer through greater integration of research with the care of our patients,” said Walter Curran Jr., M.D., executive director.

Dr. Ramalingam, a professor in Emory’s Department of Hematology and Medical Oncology, now serves as Winship’s director of Medical Oncology and its Lung Cancer Program. He co-leads Winship’s Discovery and Developmental Therapeutics Program.

Board certified in medical oncology and internal medicine, he chairs the Thoracic Malignancies Committee and serves as deputy chair for the Therapeutics Program within ECOG ACRIN Cancer Research Group, a National Cancer Institute-supported national clinical trials group. His research focuses on agents that inhibit pathways for specific lung cancer mutations. He also investigates ways to individualize therapies in patients with small-cell and non-small-cell lung cancer.

150 years in the heart of Detroit